Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis

[EN]There is evidence of continuous bidirectional cross-talk between malignant cells and bone marrow-derived mesenchymal stromal cells (BM-MSC), which favors the emergence and progression of myeloproliferative neoplastic (MPN) diseases. In the current work we have compared the function and gene expr...

Descripción completa

Detalles Bibliográficos
Autores: Ramos, Teresa L., Sánchez Abarca, Luis Ignacio, Rosón Burgo, Beatriz, Redondo Guijo, Alba María, Rico, Ana, Preciado Pérez, Silvia, Ortega, Rebeca, Rodríguez, Concepción, Muntión Olave, María Sandra, Hernández Hernández, Ángel, Rivas Sanz, Javier de las, González, Marcos, González Porras, José Ramón, Cañizo Fernández-Roldán, María Consuelo del, Sánchez-Guijo Martín, Fermín
Tipo de recurso: artículo
Fecha de publicación:2017
País:España
Institución:Universidad de Salamanca (USAL)
Repositorio:GREDOS. Repositorio Institucional de la Universidad de Salamanca
OAI Identifier:oai:gredos.usal.es:10366/135282
Acceso en línea:http://hdl.handle.net/10366/135282
https://doi.org/10.1371/journal.pone.0182470
Access Level:acceso abierto
Palabra clave:Mesenchymal stromal cells
Cell biology
Neoplastic hematopoiesis
Células madre
Neoplasias hematopoyeticas
id ES_e5ce0f38e94a70ef2a241e5a46d0b571
oai_identifier_str oai:gredos.usal.es:10366/135282
network_acronym_str ES
network_name_str España
repository_id_str
spelling Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesisRamos, Teresa L.Sánchez Abarca, Luis IgnacioRosón Burgo, BeatrizRedondo Guijo, Alba MaríaRico, AnaPreciado Pérez, SilviaOrtega, RebecaRodríguez, ConcepciónMuntión Olave, María SandraHernández Hernández, ÁngelRivas Sanz, Javier de lasGonzález, MarcosGonzález Porras, José RamónCañizo Fernández-Roldán, María Consuelo delSánchez-Guijo Martín, FermínMesenchymal stromal cellsCell biologyNeoplastic hematopoiesisCélulas madreNeoplasias hematopoyeticas[EN]There is evidence of continuous bidirectional cross-talk between malignant cells and bone marrow-derived mesenchymal stromal cells (BM-MSC), which favors the emergence and progression of myeloproliferative neoplastic (MPN) diseases. In the current work we have compared the function and gene expression profile of BM-MSC from healthy donors (HDMSC) and patients with MPN (JAK2V617F), showing no differences in the morphology, proliferation and differentiation capacity between both groups. However, BM-MSC from MPN expressed higher mean fluorescence intensity (MIF) of CD73, CD44 and CD90, whereas CD105 was lower when compared to controls. Gene expression profile of BM-MSC showed a total of 169 genes that were differentially expressed in BM-MSC from MPN patients compared to HD-MSC. In addition, we studied the ability of BM-MSC to support the growth and survival of hematopoietic stem/progenitor cells (HSPC), showing a significant increase in the number of CFU-GM colonies when MPN-HSPC were co-cultured with MPN-MSC. Furthermore, MPN-MSC showed alteration in the expression of genes associated to the maintenance of hematopoiesis, with an overexpression of SPP1 and NF-kB, and a downregulation of ANGPT1 and THPO. Our results suggest that BM-MSC from JAK2+ patients differ from their normal counterparts and favor the maintenance of malignant clonal hematopoietic cellsPublic Library of Science (New York)201720172017info:eu-repo/semantics/articlehttp://hdl.handle.net/10366/135282https://doi.org/10.1371/journal.pone.0182470reponame:GREDOS. Repositorio Institucional de la Universidad de Salamancainstname:Universidad de Salamanca (USAL)InglésAttribution-NonCommercial-NoDerivs 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:gredos.usal.es:10366/1352822026-06-07T06:28:51Z
dc.title.none.fl_str_mv Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
title Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
spellingShingle Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
Ramos, Teresa L.
Mesenchymal stromal cells
Cell biology
Neoplastic hematopoiesis
Células madre
Neoplasias hematopoyeticas
title_short Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
title_full Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
title_fullStr Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
title_full_unstemmed Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
title_sort Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
dc.creator.none.fl_str_mv Ramos, Teresa L.
Sánchez Abarca, Luis Ignacio
Rosón Burgo, Beatriz
Redondo Guijo, Alba María
Rico, Ana
Preciado Pérez, Silvia
Ortega, Rebeca
Rodríguez, Concepción
Muntión Olave, María Sandra
Hernández Hernández, Ángel
Rivas Sanz, Javier de las
González, Marcos
González Porras, José Ramón
Cañizo Fernández-Roldán, María Consuelo del
Sánchez-Guijo Martín, Fermín
author Ramos, Teresa L.
author_facet Ramos, Teresa L.
Sánchez Abarca, Luis Ignacio
Rosón Burgo, Beatriz
Redondo Guijo, Alba María
Rico, Ana
Preciado Pérez, Silvia
Ortega, Rebeca
Rodríguez, Concepción
Muntión Olave, María Sandra
Hernández Hernández, Ángel
Rivas Sanz, Javier de las
González, Marcos
González Porras, José Ramón
Cañizo Fernández-Roldán, María Consuelo del
Sánchez-Guijo Martín, Fermín
author_role author
author2 Sánchez Abarca, Luis Ignacio
Rosón Burgo, Beatriz
Redondo Guijo, Alba María
Rico, Ana
Preciado Pérez, Silvia
Ortega, Rebeca
Rodríguez, Concepción
Muntión Olave, María Sandra
Hernández Hernández, Ángel
Rivas Sanz, Javier de las
González, Marcos
González Porras, José Ramón
Cañizo Fernández-Roldán, María Consuelo del
Sánchez-Guijo Martín, Fermín
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Mesenchymal stromal cells
Cell biology
Neoplastic hematopoiesis
Células madre
Neoplasias hematopoyeticas
topic Mesenchymal stromal cells
Cell biology
Neoplastic hematopoiesis
Células madre
Neoplasias hematopoyeticas
description [EN]There is evidence of continuous bidirectional cross-talk between malignant cells and bone marrow-derived mesenchymal stromal cells (BM-MSC), which favors the emergence and progression of myeloproliferative neoplastic (MPN) diseases. In the current work we have compared the function and gene expression profile of BM-MSC from healthy donors (HDMSC) and patients with MPN (JAK2V617F), showing no differences in the morphology, proliferation and differentiation capacity between both groups. However, BM-MSC from MPN expressed higher mean fluorescence intensity (MIF) of CD73, CD44 and CD90, whereas CD105 was lower when compared to controls. Gene expression profile of BM-MSC showed a total of 169 genes that were differentially expressed in BM-MSC from MPN patients compared to HD-MSC. In addition, we studied the ability of BM-MSC to support the growth and survival of hematopoietic stem/progenitor cells (HSPC), showing a significant increase in the number of CFU-GM colonies when MPN-HSPC were co-cultured with MPN-MSC. Furthermore, MPN-MSC showed alteration in the expression of genes associated to the maintenance of hematopoiesis, with an overexpression of SPP1 and NF-kB, and a downregulation of ANGPT1 and THPO. Our results suggest that BM-MSC from JAK2+ patients differ from their normal counterparts and favor the maintenance of malignant clonal hematopoietic cells
publishDate 2017
dc.date.none.fl_str_mv 2017
2017
2017
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/10366/135282
https://doi.org/10.1371/journal.pone.0182470
url http://hdl.handle.net/10366/135282
https://doi.org/10.1371/journal.pone.0182470
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv Attribution-NonCommercial-NoDerivs 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivs 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Public Library of Science (New York)
publisher.none.fl_str_mv Public Library of Science (New York)
dc.source.none.fl_str_mv reponame:GREDOS. Repositorio Institucional de la Universidad de Salamanca
instname:Universidad de Salamanca (USAL)
instname_str Universidad de Salamanca (USAL)
reponame_str GREDOS. Repositorio Institucional de la Universidad de Salamanca
collection GREDOS. Repositorio Institucional de la Universidad de Salamanca
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869422711500963840
score 15.301603